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In This IssueControl ALT, Delete Cancer
PAGE 651
Telomerase inhibition is an emerging therapeutic approach for numerous cancers. Here, Hu
et al. demonstrate that inhibiting telomerase causes cell death in a mouse model of T cell
lymphoma, but resistant cells eventually emerge as tumors acquire alternative lengthening of
telomeres (ALT) and aberrant mitochondrial function. Surprisingly, these resistant cells are
sensitive toPGC-1bblocking, offeringa target for enhancing theeffectivenessof antitelomerase
therapy.
atTAKing Colon Cancer
PAGE 639
KRAS mutations in colon cancers define a generally chemorefractory subtype. APC muta-
tions may cooperate with mutant KRAS to drive Wnt-signaling pathways. Singh et al. identi-fied the TAK1 kinase as a key node that links KRAS to activated Wnt signaling in APC-deficient cancer cells. TAK1 inhibition leads to
apoptotic cell death and tumor regression in KRAS-dependent colon cancers, making this kinase an attractive candidate therapeutic
target for a treatment-refractory subset of colon cancers.
Polygamous Polycomb
PAGE 664
The Polycomb-repressive complexes have been thought to act hierarchically, with PRC2 catalyzing H3K27 methylation that, in turn,
recruits PRC1 to catalyze H2A ubiquitylation. Tavares et al. now show that, although this pattern holds when the PRC complex
includes the CBX subunit, an alternative PRC2 complex in which the RYBP protein replaces CBX allows for PRC1-mediated ubiq-
uitylation independent of H3K27 methylation. This alternative complex is important for ES cell maintenance and X chromosome
silencing and points to different varieties of PRCs carrying different functions.
Transcription Initiation in the Limelight
PAGE 679
Activator-dependent bacterial transcription shows many parallels to enhancer-dependent eukaryotic transcription. Using optical
microscopy, Friedman and Gelles directly observe and quantitatively define the pathway of initiation at an activator-dependent
bacterial promoter. The study identifies key constraints on and opportunities for transcription regulation at these promoters and pres-
ents an approach with broad applicability.
Elongation Factor for the PolyQ Long Haul
PAGE 690
Trinucleotide repeats encoding lengthy polyglutamine (polyQ) stretches occur in Huntington’s disease and other inherited neurolog-
ical disorders. Liu et al. find that the transcription elongation protein Spt4 is needed to transcribe elongated segments of trinucleotide
repeats both in protein-coding and nonprotein-coding regions. Spt4 deficiency selectively reduces production and aggregation of
mutant polyQ-containing proteins, revealing a potential target for the treatment of neurological disorders caused by expanded trinu-
cleotide regions.
A Lipid Hotline to TORC
PAGE 702
Using a combination of genetic, biochemical, and metabolomics approaches, Mousley et al. identify Kes1 as a mediator of
membrane trafficking and lipid signaling that modulates nutrient sensing and cellular proliferation. The Kes1 pathway bridges nutrient
transport at the plasma membrane to TORC1 signaling and Gcn4-driven transcriptional
responses, providing an example of how oxysterol-binding proteins can serve as key media-
tors for spatially distinct cellular processes.Inside the Immunoproteasome
PAGE 727
Immunoproteasomes generate peptides that differ from constitutive proteasomes, influ-
encing antigen presentation and the immune response. Selective inhibition of the immu-
noproteasome is a promising treatment for autoimmune diseases. Huber et al. now
provide structural insights into the molecular differences between the constitutive protea-
some and the immunoproteasome and explain why the immunoproteasome is more
competent in producing MHC-I ligands and why it is preferentially targeted by the inhib-
itor PR-957.Cell 148, February 17, 2012 ª2012 Elsevier Inc. 625
Harnessing Natural Killers to Fight B Cell Lymphoma
PAGE 739
In immunosuppressed patients, Epstein-Barr virus (EBV) frequently causes B cell lymphomas.
Zhang et al. establish a mouse model for this disorder through the transgenic expression of a single
EBV protein and use this model to develop a potential therapy based on tumor recognition by natural
killer cells.Modeling Mitochondrial Disease in Mice
PAGE 716
Raimundo et al. have used a transgenic approach to generate a mouse model of a deafness
syndrome that is caused by a mitochondrial mutation in humans. Their studies reveal a tissue-specific apoptotic pathway triggered
by mitochondrial stress and provide insight into the mechanism of maternally inherited deafness. This first mouse model of a mito-
chondrial disease will be valuable for addressing the complex tissue specificity of mitochondrial disease pathogenesis in general.
Axonal Mitochondria Welcome Unexpected Guest
PAGE 752
Using subcellular proteomics, Yoon et al. reveal that Lamin B2, an intermediate filament protein usually associated with the nuclear
membrane, is synthesized in axons, localizes to mitochondria, and is critical for axon maintenance. This new function for Lamin B2
could provide insight into the cell type-specific nature of some laminopathies.
JAK Sets Circadian STATus
PAGE 765
How do circadian signals in the brain control whole-organism behavior? Luo and Sehgal provide insight into this question by iden-
tifying a microRNA-JAK/STAT circuit that drives normal rhythms of rest and activity in Drosophila. They show that central clock
neurons project to a subset of neurons that secrete the cytokine-like protein Upd in a miR-279-dependent manner, tracing cellular
and molecular connections from oscillations in the central clock to circadian behaviors.
The Cost of a Single Gene
PAGE 792
Althoughmost genes in eukaryotic genomes are highly conserved, only aminority have been found to have a loss-of-function pheno-
type in genetic screens. Ramani et al. develop an assay to measure the fitness costs of losing individual gene functions over several
generations. These population-level assays reveal that the majority of worm genes are required for wild-type growth, suggesting that
genetic networks are not robust to mutation, as previously proposed.
Cdc42 Is Actin Up
PAGE 803
Cell polarity relies on the spatial assembly of signaling networks along the plasmamembrane. Here, Orchard et al. take advantage of
a simple bacterial infection paradigm to probe the molecular mechanisms underlying these processes. The E. coli protein Map,
a bacterial guanine-nucleotide exchange factor, influences host cell polarity by establishing a connection with host cell F-actin to
shape the timing and location of Cdc42 activity on the plasma membrane.
The Mammalian Methylome Base by Base
PAGE 816
What are the epigenetic differences between two haploid genomes inherited from each parent? Xie et al. generate a whole-genome,
base-resolution map of allelic DNAmethylation in the brain. They identified many loci that are differentially methylated, dependent on
the parent of origin, including at noncanonical non-CG sites. They also discovered sequence signa-
tures correlatedwith CGmethylation that are evolutionarily conserved aswell as previously unknown
loci that are subject to imprinting, including miRNAs.
The Devil’s Genome
PAGE 780
Tasmanian devil facial tumor disease (DFTD) is a transmissible cancer spread by biting that is threat-
ening the Tasmanian devil with extinction. Murchison et al. have sequenced the genome of the Tas-
manian devil as well as the genomes of two DFTD tumors. These sequences reveal that DFTD first
originated in a female devil and has acquired somatic mutations, structural variants, and copy
number alterations during its spread across Tasmania.Cell 148, February 17, 2012 ª2012 Elsevier Inc. 627
